Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT06474884

The Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield for Intracranial Aneurysms

Led by Xuanwu Hospital, Beijing · Updated on 2024-12-10

165

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this study was to evaluate the safety and efficacy of single antiplatelet therapy after Pipeline flex with Shield stent implantation for intracranial aneurysms.

CONDITIONS

Official Title

The Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield for Intracranial Aneurysms

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with unruptured intracranial aneurysms who received the intracranial Pipeline Flex with Shield stent
  • No obvious calcification or stenosis of the parent artery
  • Minimal curvature of the bearing artery
  • Parent artery diameter of at least 2.5 mm
  • Only one Pipeline Flex with Shield stent needed for aneurysm treatment
  • Standard dual antiplatelet therapy administered for at least 3 days before stent implantation
  • Modified Rankin Scale score less than 2 on the day of registration
  • Successful operation with immediate postoperative angiography indicating good wall apposition
Not Eligible

You will not qualify if you...

  • Patients with recurrent aneurysms after interventional treatment or surgical clipping
  • Patients after stent placement surgery
  • Aneurysms with irregular shapes such as fusiform, blister-type, or dissecting aneurysms
  • History of stroke or aneurysm rupture within the last 3 months
  • Abnormal platelet function or platelet count below 100,000 cells/mm³
  • Known allergy to clopidogrel or heparin

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Xuanwu Hospital, Capital Medical University

Beijing, China

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here